ADULT TOY AND RELATED NETWORK AND SERVICE-BASED INTERACTION
#602WEARABLE DEVICE FOR VIBRATORY STIMULATION AND METHODS OF USE
#603VIBROACOUSTIC DEVICES, SYSTEMS, AND METHODS FOR PROMOTING REST
#604HEAD-MOUNTED CLAMPING-TYPE HEAD MASSAGE DEVICE
#605MULTIFUNCTIONAL WAIST PHYSIOTHERAPY INSTRUMENT
#606FOOT MASSAGER
#607Pressure Pad Headgear Device
#608NFC-ENABLED MEDICAL DEVICE SYSTEM AND PROCESSES FOR GENERATING ASSOCIATED INFORMATION LAYER
#609GLASS CONTAINERS FOR PACKAGING SALT OR SUGAR-CONTAINING COMPOSITIONS IN A FROZEN STATE
#610CONTAINER WITH THREADED CONNECTOR
#611VIAL HOLDER
#612INSTALLATION FOR PRODUCING A MEDICAL PREPARATION
#613KEYED MEDICATION CARTRIDGE FOR USE IN A HANDHELD ORAL MEDICATION DISPENSING DEVICE
#614MEDICATION DISPENSING SYSTEM HAVING A HANDHELD ORAL MEDICATION DISPENSING DEVICE WITH KEYED MEDICATION CARTRIDGE
#615SINGLE-USE MULTI-COMPARTMENT BABY FORMULA POUCH
#616DENTAL COMPOSITION
#617MULTILAYER DISSOLVABLE SOLID ARTICLE CONTAINING COATING COMPOSITION AND PROCESS FOR MAKING THE SAME
#618SOLID COSMETIC CARE COMPOSITION COMPRISING AT LEAST ONE CAVITY
#619SOLID COSMETIC COMPOSITION COMPRISING AT LEAST ONE CAVITY
#620HYDROGEN PEROXIDE TEETH WHITENING GEL
#621HAIR CONDITIONING COMPOSITION
#622Calming Sunscreen Body Butter
#623AQUEOUS LIQUID COSMETIC
#624PLANT PROTEIN-BASED MICROCAPSULES
#625POWDERS HAVING IMPROVED DISPERSABILITY AND USE THEREOF IN COMPOSITIONS AND ARTICLES OF MANUFACTURE
#626POWDER AND LIQUID COMPOSITIONS FOR DENTAL CARE, AND METHODS OF USE THEREOF
#627Dentifrice Compositions Comprising Tin Ions
#628NON-AQUEOUS DENTIFRICE COMPOSITION
#629Hair Care Composition
#630TOPICAL HYDRATION COMPOSITIONS
#631PEPTIDE HAVING ACTIVITY OF PREVENTING HAIR LOSS OR PROMOTING HAIR GROWTH AND USE THEREOF
#632Cosmetic and Personal Care compositions
#633Skincare Formulation for Multi-Modal Reduction of Acetylcholine Concentration and Activity
#634TOPICAL COMPOSITIONS AND METHODS
#635OIL-BASED COSMETIC
#636NON-THERAPEUTIC USE OF HYPERBRANCHED DEXTRINS AS A SOOTHING AGENT
#637POLYESTER, VISCOUS MIXTURE, PROCESS FOR PREPARING SAME AND COSMETIC COMPOSITION
#638FOAMING MIXED ALCOHOL/WATER COMPOSITIONS COMPRISING A COMBINATION OF ALKYL SILOXANE AND A HYDROTROPE/SOLUBILIZER
#639SURFACTANT COMPOSITION AND COSMETIC
#640NATURAL COSMETIC PROCESS AND COMPOSITION
#641COMPOSITIONS COMPRISING BREVIBACILLA MULTIFUNCTIONAL FERMENTATES AND METHODS OF USE
#642AMMONIA OXIDIZING MICROORGANISMS FOR PH MODULATION
#643OSMOTIC PUMP TABLET, PREPARATION METHOD THEREFOR AND USE THEREOF
#644EFFERVESCENT COMPOSITION AND METHOD FOR DETERMINING BITTERNESS PERCEPTION
#645TOPICAL DELIVERY OF EPINEPHRINE AND PRODRUG COMPOSITIONS
#646BODY CAVITY GEL
#647ADMINISTRATION OF BENZODIAZEPINE COMPOSITIONS
#648OPHTHALMIC PREPARATION FOR TREATING MACULAR EDEMA, OPTIC NEURITIS AND NON-INFECTIOUS ENDOPHTHALMITIS THROUGH EYE DROP ADMINISTRATION
#649METHODS AND COMPOSITIONS FOR ORAL ADMINISTRATION
#650FORMULATIONS OF A PLASMA KALLIKREIN INHIBITOR
#651ORAL RECEPTACLE
#652A MUCOADHESIVE FILM COMPRISING A PHARMACEUTICALLY ACTIVE AGENT AND USES THEREOF
#653Pharmaceutical Formulation
#654DEVICES AND METHODS FOR DELIVERY OF SUBSTANCES TO ANIMALS
#655COMPOSITIONS FOR LOCAL THERAPY DELIVERY TO BRAIN TUMORS AND METHODS
#656FORMULATIONS
#657COMPOSITION FOR USE IN PRESSURISED DISPENSING CONTAINER
#658POLYMERSOMES COMPRISING A SOLUBLE ENCAPSULATED POLYNUCLEOTIDE AND AN IONIZABLE LIPID AS WELL AS METHODS OF MAKING AND USES THEREOF
#659COMPOUNDS, COMPOSITIONS AND METHODS FOR DELIVERY OF BIOLOGICALLY ACTIVE AGENTS
#660LIPID DEPOT FORMULATIONS
#661AMORPHOUS SOLID DISPERSIONS AND PHARMACEUTICAL COMPOSITIONS COMPRISING THE SAME
#662CANNABINOIDAL COMPOSITIONS AND METHODS OF PRODUCING THE SAME
#663HIGH-THROUGHPUT PREPARATION OF MICROPARTICLES WITH PULSATILE RELEASE
#664TARGET-SPECIFIC THROMBOLYTIC UROKINASE MICROSPHERES AND METHOD TO DISSOLVE SICKLE DISEASE CLOTS
#665Pharmaceutical formulations comprising tenofovir alafenamide and emtricitabine
#666PHARMACEUTICAL COMPOSITION
#667HIGH DOSE ENDOXIFEN FORMULATIONS AND METHODS OF USE
#668EXOSOMES EXPRESSING RSVF AND USE THEREOF
#669COATED NANOPARTICLE AGGREGATES COMPOSED OF A HYDROLYZED METAL SALT AND METHODS OF USE THEREOF
#670MESOPOROUS SILICA NANOPARTICLES WITH LIPID BILAYER COATING FOR CARGO DELIVERY
#671LIPID NANOPARTICLE FORMULATIONS AND METHODS OF SYNTHESIS THEREOF
#672LIPID AMINES
#673MACROPHAGE IMMUNOTHERAPY
#674COMPOSITIONS FOR SUPPLEMENTING PRODUCTS WITH THERAPEUTIC AGENTS AND METHODS OF USE THEREOF
#675CATIONIC LIPIDS CONTAINING SILICON
#676VESICLES AND USES THEREOF
#677SMALL MOLECULE ANTAGONISTS OF PF4
#678METHODS FOR TREATING SKIN DISORDERS WITH A TOPICAL COMPOSITION OF BIS-(2-CHLOROETHYL)METHYLAMINE
#679R-KETAMINE LIQUID PREPARATION AND USE THEREOF
#680METHODS FOR TREATING NEURODEVELOPMENTAL DISORDERS VIA ADMINISTRATION OF ORGANIC TRICYCLIC COMPOUNDS
#681Method Of Treating Major Depressive Disorder
#682Novel Treatment Method for Painful Musculoskeletal Conditions
#683BUPROPION AS A MODULATOR OF DRUG ACTIVITY
#684Topical Antimicrobial Lotion for Treating Pyotraumatic Dermatitis Lesions
#685KETOROLAC TROMETHAMINE COMPOSITIONS FOR TREATING OR PREVENTING OCULAR PAIN
#686NOVEL DERIVATIVE COMPOUND HAVING BIPHENYL GROUP INTRODUCED INTO AMINO-ALKANOIC ACID AND ANTI-INFLAMMATORY COMPOSITION COMPRISING SAME
#687OPHTHALMIC PHARMACEUTICAL COMPOSITIONS AND USES THEREOF
#688CHEWABLE GUMMY CONTAINING BETA-HYDROXY BETA-METHYLBUTYRIC ACID (HMB)
#689LUBRICANT
#690METHODS OF TREATMENT OF CHOLESTATIC DISEASES
#691COMPOSITIONS AND METHODS USING AT LEAST ONE GLYCINE OR DERIVATIVE THEREOF AND/OR AT LEAST ONE N-ACETYLCYSTEINE OR DERIVATIVE THEREOF, AND AT LEAST ONE THYMOL AND/OR CARVACROL
#692USE OF L-ASPARTIC ACID BETA-HYDROXAMATE (L-ABH) IN PREPARATION OF DRUG FOR DIABETIC RETINOPATHY (DR) OR RETINOPATHY OF PREMATURITY (ROP)
#693METHOD TO IMPROVE GROWTH PERFORMANCE, LIVABILITY, CARCASS CHARACTERISTICS AND/OR MILK QUALITY IN SWINE
#694ORODISPERSIVE DOSAGE FORMS CONTAINING DROXIDOPA
#695COMPOSITIONS COMPRISING 15-HEPE AND METHODS OF USING THE SAME
#696OIL-IN-WATER EMULSIONS AND USES THEREOF IN RESISTING INFANTILE ECZEMA
#697COMPOUND WITH NEW SKELETON OF URSANE TRITERPENOID - ENT-KAURANE DITERPENOID DIMER, AND PREPARATION METHOD THEREOF AND APPLICATION THEREOF
#698Method of dietary treatment for genetic and epigenetic diseases and disorders
#699COMPOSITIONS, SYSTEMS, AND METHODS FOR TREATING CANCER IN STANDARD OF CARE AND/OR PROFIBROTIC CHEMOTHERAPEUTIC AGENT-NAÏVE PATIENTS USING TUMOR TREATING FIELDS AND CHEMOTHERAPEUTIC AGENTS
#700SIGMA-1 RECEPTOR AGONIST SYSTOLIC BLOOD PRESSURE THERAPY
#701Cardioversion Methods Using Budiodarone
#702NITROGEN-CONTAINING ANALOGS OF SALINOMYCIN FOR USE IN MULTIPLE MYELOMA (MM)
#703PEPTIDE PHARMACEUTICALS FOR TREATMENT OF NASH AND OTHER DISORDERS
#704COMPOSITIONS AND METHODS FOR MODULATING SLEEP AND USES THEREOF
#705CHIRAL ARYL PROPIONIC ACID DERIVATIVE AND PHARMACEUTICAL COMPOSITION THEREOF, AND USE
#706COMBINATION THERAPIES COMPRISING QTX125
#707METHODS OF IMPROVING RENAL FUNCTION
#708COMPOSITIONS AND METHODS FOR NEUROABLATION
#709METHODS OF TREATING CANCER BY INHIBITING BACTERIAL DNAK TO RESTORE ACTIVITIES OF ANTICANCER DRUGS
#710TREATMENT OR PREVENTION OF DENGUE VIRAL INFECTION
#711DIALKYL TRYPTAMINES AND THEIR THERAPEUTIC USES
#712LIPIDS, FORMULATIONS, AND USES THEREOF
#713PEGYLATED BILIRUBIN FOR THE TREATMENT OF HYPERLIPIDEMIA, OBESITY, FATTY LIVER DISEASE, CARDIOVASCULAR DISEASES AND TYPE II DIABETES
#714USE OF MEBENDAZOLE FOR TREATING VIRAL INFECTION
#715THERAPEUTICALLY EFFECTIVE ORAL ADMINISTRATION OF A 2 ARYLBENZIMIDAZOLE
#716DOSING REGIMEN FOR A SELECTIVE S1P1 RECEPTOR AGONIST
#717TREATMENT OF PATHOGENIC NEISSERIA SP. INFECTION WITH TRIAZOLE ANTIFUNGAL AGENTS
#718MOLECULES THAT ENHANCE EXTRACELLULAR VESICLE RELEASE
#719USE OF CLOPIDOGREL OR COMBINATIONS THEREOF TO TREAT AMYOTROPHIC LATERAL SCLEROSIS, DAMAGES CAUSED BY THE NORMAL AGING PROCESS, NERVE INJURIES, MUSCULAR DYSTROPHY, STRENUOUS PHYSICAL ACTIVITIES AND OTHER CONDITIONS THAT AFFECT SYNAPSES AS WELL AS SKELETAL MUSCLES
#720MODULATORS OF INTRACELLULAR CHLORIDE CONCENTRATION FOR USE IN THE TREATMENT OF COGNITIVE DECLINE
#721COMPOSITIONS AND METHODS FOR TREATING INFLAMMATORY BOWEL DISEASE AND FUSOBACTERIA-CAUSED OR RELATED DISEASES AND CONDITIONS
#722RIFABUTIN TREATMENT METHODS, USES, AND COMPOSITIONS
#723COMPOSITIONS FOR THE TREATMENT OF NON-ALCOHOLIC FATTY LIVER DISEASE AND NON-ALCOHOLIC STEATOHEPATITIS
#724TOPICAL ROFLUMILAST FORMULATION HAVING IMPROVED DELIVERY AND PLASMA HALF- LIFE
#725OPHTHALMIC COMPOSITION INHIBITING OCCURRENCE OF N-OXOPYRIDINE COMPOUND FOR PREVENTING OR TREATING EYE DISEASE
#726CDK Inhibitors And Their Use As Pharmaceuticals
#727PHARMACEUTICAL COMPOSITION FOR TREATING COGNITIVE DECLINE OR FOR TREATING OVERWEIGHTNESS OR OBESITY
#728A PHARMACEUTICAL COMPOSITION OF PITOLISANT HYDROCHLORIDE AND THEIR PROCESS FOR THE PREPARATION
#729EFINACONAZOLE ORAL COMPOSITION
#730TREATMENT OF CNS CONDITIONS
#731METHODS FOR PREVENTING OR TREATING KIDNEY DISEASES
#732TREATMENT OF CAVERNOUS ANGIOMAS WITH A 4-SUBSTITUTED PIPERIDINE DERIVATIVE
#733PHARMACEUTICAL DRY POWDER INHALATION FORMULATION
#734NALTREXONE FOR BOOSTING THE THERAPEUTIC UTILTY OF 5-HT RECEPTOR AGONISTS
#735BILE ACID RECYCLING INHIBITORS FOR TREATMENT OF PEDIATRIC CHOLESTATIC LIVER DISEASES
#736TRANSCRIPTION FACTOR EB ACTIVATORS AND USES THEREOF
#737METHODS OF IMPROVING LUNG FUNCTION
#738DIAGNOSIS AND/OR TREATMENT OF HEART FAILURE WITH PRESERVED EJECTION FRACTION
#739THERAPEUTIC STRATEGIES TO MANAGE FACIAL CONTRACTURES POST INJURY
#740CDK INHIBITORS
#741VCP INHIBITORS AND USES THEREOF FOR TREATMENT
#742BIOMARKERS FOR PREDICTING SENSITIVITY TO CANCER TREATMENTS
#743RUC-4 FORMULATIONS
#744DUAL FUNCTIONING IMMUNE MODULATING COMPOUNDS, FORMULATIONS, AND USES THEREOF
#745NEW CRYSTALLINE FORMS OF SALT OF 7-CYCLOPENTYL-2-(5-PIPERAZIN-1-YL-PYRIDIN-2-YLAMINO)-7H-PYRROLO[2,3-D]PYRIMIDINE -6-CARBOXYLIC ACID DIMETHYLAMIDE
#746METHODS FOR TREATING CONGENITAL EPIDERMAL HYPERPLASIA AND COMPOSITIONS FOR SAME
#747COMPOSITIONS AND METHODS FOR THEIR PRODUCTION
#748METHODS FOR INHIBITING INFLAMMATION AND PROGRESSION OF ATHEROSCLEROTIC PLAQUES AND CARDIOVASCULAR EVENTS IN PATIENTS WITH CEREBRO- AND CARDIO-VASCULAR DISEASE
#749METHODS OF TREATING NEUROPATHY USING FORETINIB AND COMPOSITIONS THEREOF
#750FUSED AMINO PYRIMIDINE COMPOUNDS FOR TREATMENT OF SEIZURE DISORDERS
#751FUSED AMINO PYRIMIDINE COMPOUNDS FOR TREATMENT OF SYNUCLEINOPATHIES AND TDP-43 PROTEINOPATHIES
#752FUSED AMINO PYRIMIDINE COMPOUNDS FOR TREATMENT OF NEUROPATHIC AND NEURO-INFLAMMATORY PAIN
#753FUSED AMINO PYRIMIDINE COMPOUNDS AND PRIDOPIDINE FOR TREATMENT OF HUNTINGTON’S DISEASE
#754SALTS AND SOLID FORMS OF (S)-3-(4-((4-(MORPHOLINOMETHYL)BENZYL)OXY)-1-OXOISOINDOLIN-2-YL)PIPERIDINE-2,6-DIONE AND COMPOSITIONS COMPRISING AND METHODS OF USING THE SAME
#755NEW DRUG APPLICATION
#756DO3A-BASED ANTITHROMBOTIC AGENT OR HEMOLYTIC AGENT CONTAINING GADOLINIUM COMPLEX
#757Method for improving insulin insensitivity
#758METHODS AND COMPOSITIONS FOR TESTOSTERONE PRODUCTION
#759APPLICATION OF HYDROXYPROGESTERONE CAPROATE IN ENHANCING TUMOR TREATMENT EFFECT
#760METHODS OF TREATING NEPHROTIC SYNDROME
#761CATIONIC STEROIDAL ANTIMICROBIAL SALTS
#762SEQUENTIAL HORMONE THERAPY TO IMPROVE SURVIVAL AND ENHANCE RESPONSE TO IMMUNE THERAPY IN MEN WITH PROSTATE CANCER
#763COMBINED THERAPY OF 4'-THIO-5-AZA-2'-DEOXYCYTIDINE AND VENETOCLAX
#764N-(PHENYLSULFONYL)BENZAMIDES AND RELATED COMPOUNDS AS BCL-2 INHIBITORS
#765BUFFERING AGENT-CONTAINING COMPOSITIONS AND METHODS OF USING SAME
#766USE OF PSYCHEDELICS TO TREAT DEMENTIA
#767TREATMENT OF CANCER PATIENTS HAVING KRAS MUTATIONS
#768CARBORANE COMPOUNDS, CARBORANE ANALOGS, AND METHODS OF USE THEREOF
#769NUTRACEUTICAL FORMULATION FOR POLYCYSTIC OVARY SYNDROME
#770SENOLYSIS BY AMMONIA-LOWERING COMPONENT
#771METHODS AND AGENTS FOR PREVENTING SKELETAL AGING, OSTEOPOROSIS AND OBESITY
#772NUCLEOTIDE AND NUCLEOSIDE THERAPEUTIC COMPOSITIONS, COMBINATIONS AND USES RELATED THERETO
#773ADVANTAGEOUS ANTI-HCV COMBINATION THERAPY
#774COMPOSITIONS FOR THE TREATMENT OF DRY EYE
#775HYDROXYPROPYL BETA-CYCLODEXTRIN COMPOSITIONS AND METHODS
#776SULFATED GLYCOSAMINOGLYCAN COMPOUNDS, METHODS, AND USES THEREOF
#777THERAPY OF HIGH-RISK HUMAN PAPILLOMAVIRUS INFECTIONS
#778CALCIUM OR MAGNESIUM CHLORIDE SALT-BASED COMPOSITION
#779Compositions Comprising Stable Free Available Chlorine Species and Peroxides, Methods of Making and Uses Thereof
#780COMPOSITIONS AND METHODS FOR THE TREATMENT OF CANCER CELLS BY INDUCTION OF CYTOTOXIC OXIDATIVE STRESS
#781GRAPHENE OXIDE-CATIONIC SILVER NANOCOMPOSITES AND THEIR USE AS BROAD-SPECTRUM ANTIMICROBIAL AGENTS
#782TREATMENT OF DISEASES AND CONDITIONS OF THE EYE
#783METHODS OF PREPARING COHN POOL CONCENTRATE FROM BLOOD PLASMA THROUGH ULTRAFILTRATION
#784METHODS AND COMPOSITIONS FOR DETOXIFICATION OF CHRONIC EXPOSURE TO TOXINS
#785METHODS FOR DIAGNOSING OR TREATING HEALTH CONDITIONS OR OPTIMIZING THERAPEUTIC EFFICACY OF CAR-T CELLS THERAPIES
#786POLYPEPTIDE SPECIFIC FOR MUCIN 1 AND USE THEREOF
#787METHODS AND COMPOSITIONS FOR IMPROVING IMMUNOTHERAPY
#788ANTI-HUMAN CD45RC BINDING DOMAINS AND USES THEREOF
#789CD4-SPECIFIC ANTIBODY CONSTRUCTS AND COMPOSITIONS AND USES THEREOF
#790TREATMENT OF CANCER PATIENTS WITH TUMOR INFILTRATING LYMPHOCYTE THERAPIES IN COMBINATION WITH AN IL-15R AGONIST
#791COMPOSITIONS TARGETING GPC2 AND GPC3 AND THEIR USE FOR TREATING SOLID TUMORS
#792METHODS OF CULTURING TUMOR INFILTRATING LYMPHOCYTES
#793Methods for Haematopoietic Stem Cell Transplantation
#794COMPOSITION FOR WOUND TREATMENT COMPRISING STEM CELL-DERIVED EXTRACELLULAR VESICLES WITH ENHANCED EFFICACY
#795MESENCHYMAL STEM CELLS FOR ORAL INFLAMMATION TREATMENT
#796PREVENTION OF AUTOIMMUNE DIABETES
#797GENE THERAPY FOR BLEEDING DISORDERS
#798Human Adipose-Derived Stem Cell Exosomes And Their Packaging For Use At Room Temperature
#799Multi-Nutrient Delivery Composition
#800Fish Oil Traditional Chinese Medicine Complex with Comprehensive Blood Lipid Regulating Effect and Preparation Method and Application thereof
#801ANTIMICROBIAL COMPOSITIONS COMPRISING EXTRACELLULAR VESICLES AND METHODS THEREOF
#802PROPHYLACTIC OR THERAPEUTIC COMPOSITION FOR GRAFT-VERSUS-HOST DISEASE
#803COMPOSITIONS AND METHODS FOR IMPROVING MITOCHONDRIAL FUNCTION
#804AMMONIA OXIDIZING MICROORGANISMS FOR THE TREATMENT OF PULMONARY HYPERTENSION
#805AIRWAY MEDICAMENTS
#806BACTERIOPHAGE THERAPY AGAINST ADHERENT-INVASIVE ESCHERICHIA COLI
#807COMPOSITION FOR IMPROVING DRUG SENSITIVITY OF ANTIBACTERIAL DRUG TO METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS (MRSA), COMPOSITION FOR TREATING OR PREVENTING MRSA INFECTION, AND COMPOSITION FOR REDUCING VIRULENCE OF MRSA
#808BACTERIOPHAGE COMPOSITIONS AND METHODS FOR TREATMENT OF BACTERIAL INFECTIONS
#809PRODUCTION OF RNA POLYNUCLEOTIDES ENCODING PICORNAVIRUS
#810METHODS FOR CASCADE AMPLIFICATIONS OF THERAPEUTIC PAYLOADS (CATP) & COMPOSITIONS FOR CANCER IMMUNOTHERAPIES AND GENE THERAPY
#811Composition and Method for Treating Colic in Infants
#812DRUG FOR TREATMENT OF BREAST CANCER WITH ANTLER AND GINSENG AS SOVEREIGN DRUG AND PREPARATION METHOD AND APPLICATION THEREOF
#813METHOD FOR PREVENTING AND/OR TREATING CANCER OR AUTOIMMUNE DISEASE WITH 3,4,2 Prime,3 Prime,4 Prime-PENTAHYDROXY-TRANS-CHALCONE
#814APPLICATION OF LYCIUM BARBARUM LEAF EXTRACT IN PREPARING DRUG FOR TREATING DIABETIC RETINOPATHY
#815METHOD AND COMPOSITION FOR IMPROVING MUSCLE PERFORMANCE
#816COMPOSITIONS AND METHODS FOR HAIR TREATMENT
#817DYSREGULATION OF NEUROPROTEASOMES BY APOE ISOFORMS DRIVES ENDOGENOUS TAU AGGREGATION
#818PROBIOTIC BACTERIAL MOLECULES AND THEIR USE IN METHODS TO TREAT/PREVENT INFECTION BY HARMFUL BACTERIA AND TO PROVIDE NUTRITIONAL HEALTH
#819EXTENDED-RELEASE INJECTABLE GEL FORMULATIONS CONTAINING ANGIOTENSIN-(1-7) OLIGOPEPTIDES OR VARIANTS THEREOF
#820DESMOPRESSIN ORAL COMPOSITIONS
#821METHOD FOR TREATING OR PREVENTING DRUG-INDUCED LIVER INJURY WITH PEPTIDE COMPOSITION
#822COMPOSITIONS AND METHODS FOR TREATING NEUROENDOCRINE TUMORS
#823Treatment of Myasthenia Gravis with Zilucoplan
#824THERAPEUTIC DRUG FOR MYOTONIC DYSTROPHY TYPE 1
#825COMPOSITIONS AND METHODS FOR TREATING AND PREVENTING METABOLIC DISORDERS
#826Methods of Treating Retinal Degenerative Diseases Using AIMP2-DX2 and Optionally a Target Sequence for miR-142 and Compositions Thereof
#827COMPOSITIONS AND METHODS FOR TREATING COMPLICATIONS OF VIRAL INFECTIONS AND OTHER RESPIRATORY DISORDERS
#828METHODS FOR THE TREATMENT OF DIABETES-ASSOCIATED AUTONOMIC NEUROPATHY
#829PROPHYLACTIC ADMINISTRATION METHOD AGAINST RESPIRATORY VIRUS, COMPRISING ADMINISTERING INTERFERON-BETA TO POTENTIAL RESPIRATORY VIRUS-INFECTED SUBJECT
#830USE OF GLP-1 RECEPTOR AGONISTS TO TREAT IMPULSE-CONTROL DISORDERS
#831METHODS OF USING A GIP/GLP1 CO-AGONIST FOR THERAPY
#832Methods and Compositions for Oral Administration of Proteins
#833COMPOSITIONS, METHODS AND USES FOR TREATING CYSTIC FIBROSIS AND RELATED DISORDERS
#834METHODS OF CANCER TREATMENT BY INTRATUMORAL INJECTION OF MUTANT COLLAGENASE
#835TREATMENT OF PRURITUS IN HORSES
#836COMPOSITION OF MRNA-ENCODED IL15 FUSION PROTEINS AND METHODS OF USE THEREOF
#837ACTIVE VACCINATION FOR THE TREATMENT OF NGF-RELATED DISORDERS
#838VETERINARY COMPOSITIONS OF MODIFIED VIRUS-LIKE PARTICLES OF CMV AND IL-1 BETA MUTEIN ANTIGENS
#839VETERINARY COMPOSITIONS OF MODIFIED VIRUS-LIKE PARTICLES OF CMV AND CANINE IL-1 BETA MUTEIN ANTIGENS
#840VETERINARY COMPOSITIONS OF MODIFIED VIRUS-LIKE PARTICLES OF CMV AND FELINE IL-1 BETA MUTEIN ANTIGENS
#841PREVENTION AND TREATMENT OF INFECTIONS WITH INTRACELLULAR BACTERIA
#842COMPOSITIONS AND METHODS FOR ELICITING AN IMMUNE RESPONSE PROTECTIVE AGAINST LYME DISEASE
#843IMMUNOGENIC COMPOSITIONS COMPRISING CONJUGATED ESCHERICHIA COLI SACCHARIDES AND USES THEREOF
#844STAPHYLOCOCCUS AUREUS VACCINE COMPOSITIONS
#845IMMUNOGENIC COMPOSITION WITH PROTEIN MICRO- AND NANOPARTICLES
#846Nucleoside-modified mRNA-lipid nanoparticle lineage vaccine for hepatitis C virus
#847TRUNCATED RECOMBINANT L1 PROTEIN OF HUMAN PAPILLOMAVIRUS
#848NOVEL INFLUENZA ANTIGENS
#849IONIZABLE CATIONIC COMPOUND
#850A VACCINE FOR THE PROTECTION OF PIGLETS AGAINST SWINE INFLUENZA A VIRUS INFECTION
#851DNA DISPLAY OF FOLDED RNA LIBRARIES ENABLING RNA-SELEX WITHOUT REVERSE TRANSCRIPTION
#852COMPOSITION COMPRISING ENGINEERED PLANT-DERIVED EXTRACELLULAR VESICLES AND USE THEREOF AS A VACCINE
#853NOVEL COMPOSITIONS OF MATTER COMPRISING STABILIZED CORONAVIRUS ANTIGENS AND THEIR USE
#854VACCINATION AGAINST BACTERIAL AND BETACORONAVIRUS INFECTIONS
#855Replicon Compositions and Methods of Using Same for the Treatment of Diseases
#856Compositions for the Treatment of Infectious Disease Related Complications and Methods Thereof
#857mRNA vaccine for porcine Deltacoronavirus, preparation method and application thereof
#858Antigenic Epstein Barr Virus Polypeptides
#859CANNABIDIOL FOR AUGMENTING VACCINE MEDIATED IMMUNITY AND PROPHYLAXIS OF COVID-19
#860MEDICAMENT FOR TREATMENT AND/OR PREVENTION OF CANCER
#861STABLE FORMULATIONS FOR TNF-alpha ANTIBODIES AND USES THEREOF
#862COMPOSITION FOR TREATING OR PREVENTING CANCER
#863P2RY2 ACTIVITY MODULATORS
#864NOVEL CELL THERAPY SYSTEM
#865CD27-EXTRACELLULAR DOMAIN CAR TO TARGET CD70-POSITIVE TUMORS
#866ENHANCING SAFETY OF T-CELL-MEDIATED IMMUNOTHERAPY
#867CHIMERIC RECEPTORS COMPRISING INTERLEUKIN 7 RECEPTOR (IL7R) DOMAINS
#868SYSTEMS AND METHODS FOR TREATING CANCERS OF THE SKIN
#869METHODS FOR TREATING NEOPLASTIC DISEASES
#870Drug Delivery System
#871PROCESS FOR REDUCING SUBVISIBLE PARTICLES IN A PHARMACEUTICAL FORMULATION
#872DOCETAXEL-ACONITIC ANHYDRIDE CONJUGATE EXHIBITING ANTI-TUMOR ACTIVITY WITHOUT IN VIVO TOXICITY
#873HYDROXYBISPHOSPHONIC DERIVATIVES OF MELOXICAM FOR THE TREATMENT OF INFLAMMATORY JOINT DISEASES
#874GPC3 APTAMERS AND VARIANTS AND USE THEREOF
#875FN3 DOMAIN-siRNA CONJUGATES AND USES THEREOF
#876HETEROBIFUNCTIONAL COMPOUNDS AND THEIR USE IN TREATING DISEASE
#877METHODS AND COMPOSITIONS FOR TREATING CHRONIC INFLAMMATORY INJURY, METAPLASIA, DYSPLASIA AND CANCERS OF EPITHELIAL TISSUES
#878FOLIC ACID-CONJUGATED AMINOCLAY BASED NANOCOMPOSITES FOR THE SITE-SPECIFIC DRUG DELIVERY, METHOD FOR THEIR PREPARATION AND THEIR USE
#879MANNOSE 3 GLYCAN-MEDIATED PROTEIN DEGRADATION
#880CANCER-TARGETING PEPTIDE, PRODRUG NANOPARTICLES COMPRISING SAME, AND PHARMACEUTICAL COMPOSITION COMPRISING SAME FOR CANCER PREVENTION OR TREATMENT
#881COMPOSITE NANOPARTICULATE MINERALIZED COLLAGEN GLYCOSAMINOGLYCAN MATERIALS WITH TIME RELEASE ANTI-RESORPTIVE FACTORS
#882COMPOSITIONS AND METHODS FOR ANTI-PHOSPHOCHOLINE ACTIVE IMMUNOTHERAPY
#883PHARMACEUTICAL COMPOSITION FOR CANCER TREATMENT AND/OR PREVENTION
#884ANTIBODY-DRUG CONJUGATES AND PREPARATION METHODS AND USE THEREOF
#885LGALS3BP ANTIBODY-DRUG-CONJUGATE AND ITS USE FOR THE TREATMENT OF CANCER
#886HER2 TARGETING FC ANTIGEN BINDING FRAGMENT-DRUG CONJUGATES
#887CONJUGATES COMPRISING A PHOSPHORUS (V) AND A DRUG MOIETY
#888EXTRACELLULAR VESICLE COMPOSITES AND THEIR USES IN THE TREATMENT OF LIVER INJURY
#889CHEMICALLY AND PHOTOCHEMICALLY INITIATED CELL MEMBRANE BLEBBING TO INDUCE CELL VESICLE PRODUCTION, MODIFICATIONS THEREOF, AND USES THEREOF
#890AU, AG AND RICH PHYTOCHEMICAL PAYLOAD NANOMATERIALS, ANTIVIRAL/ANTIBACTERIAL PRODUCTS AND SYNTHESIS METHODS
#891Compositions and Methods for Activating Natural Killer Cells
#892COMPOSITIONS AND METHODS FOR TREATING CHRONIC PAIN AND FOR RETROGRADE TRANSDUCTION OF NEURONS
#893NUCLEIC ACID HAVING PROMOTER ACTIVITY AND USE THEREOF
#894VECTORS FOR DELIVERY OF HUMAN GROWTH HORMONE GENE AND MULTIPLE THERAPEUTIC GENES INTO CENTRAL NERVOUS SYSTEM BY CROSSING BLOOD BRAIN BARRIER
#895POLYNUCLEOTIDE FOR TREATMENT OF NEURODEGENERATIVE DISEASE, VECTOR, CELL, PHARMACEUTICAL COMPOSITION, AND SCREENING METHOD
#896SELECTED AAV COMPOSITIONS HAVING PREFERRED BRAIN ENRICHMENT
#897LENTIVIRAL VECTORS AND USES THEREOF
#898Lentiviral Vector
#899PLASMID DNA CONSTRUCTS FOR THERAPEUTIC PROTEIN EXPRESSION
#900STEALTH LIPID NANOPARTICLE COMPOSITIONS FOR CELL TARGETING